Animal biotechnology market seen topping $53 billion by 2030

By AI, Created 11:11 AM UTC, May 20, 2026, /AGP/ – The Business Research Company says the animal biotechnology market will grow from $32.89 billion in 2025 to $36.19 billion in 2026, with longer-term expansion to $53.4 billion by 2030. The report points to rising animal health demand, gene-editing tools and AI-driven monitoring as the biggest growth drivers, with Asia-Pacific expected to be the fastest-growing region.

Why it matters: - The animal biotechnology market is expanding as livestock, companion animal and veterinary health needs grow. - The market’s projected rise to $53.4 billion by 2030 signals sustained demand for tools that improve animal productivity, disease prevention and food safety. - The report’s outlook also points to growing commercial use of biotechnology in pharmaceuticals, diagnostics and reproduction.

What happened: - The Business Research Company released its Animal Biotechnology Market Report 2026 on May 4, 2026. - The report estimates the market will grow from $32.89 billion in 2025 to $36.19 billion in 2026. - The report forecasts a compound annual growth rate of 10.0% from 2025 to 2026. - The report projects the market will reach $53.4 billion by 2030, at a 10.2% CAGR. - North America led the market in 2025. - Asia-Pacific is expected to grow the fastest during the forecast period.

The details: - The report links near-term growth to recombinant vaccine technology, rising animal disease incidence, larger companion and livestock populations, stronger demand for animal-derived pharmaceuticals and more veterinary diagnostic services. - The report says future growth will be supported by precision gene-editing technologies, preventive veterinary care, biopharmaceutical applications, reproductive technologies and AI plus big data for animal-health monitoring. - Key trends include broader use of genetic engineering in livestock, personalized veterinary treatments, immunodiagnostics, molecular tests, artificial insemination, embryo transfer, nutraceuticals and feed additives. - Animal biotechnology is defined in the report as the use of scientific and engineering techniques to alter living organisms for human and animal benefit. - Genetic engineering is presented as a core application for improving traits used in pharmaceutical production, industrial uses and agriculture. - The report says the technology is intended to improve productivity, health and resource efficiency across animal-related sectors. - The company provides a free sample of the report. - The company also offers the full animal biotechnology market report.

Between the lines: - Rising concern about animal health and welfare is becoming a commercial driver for biotech tools that improve growth rates, reproduction quality, nutrition and feed efficiency. - The report’s regional split suggests the market is already mature in North America while new growth is shifting toward Asia-Pacific. - The emphasis on AI, big data and precision gene editing suggests the market is moving from broad animal-health products toward more targeted and data-driven applications. - A May 2023 Humane Society campaign cited in the report helped more than 14,800 pets receive around 64,000 veterinary services through outreach in low-resource communities.

What’s next: - The market is expected to keep expanding through 2030 as preventive care, genetic engineering and advanced diagnostics gain wider adoption. - Reproductive technologies such as artificial insemination and embryo transfer are likely to become more common in animal biotechnology workflows. - Investors and operators will likely watch Asia-Pacific for the fastest regional growth and North America for continued market leadership.

The bottom line: - Animal biotechnology is moving from a niche science tool to a broader platform for animal health, productivity and food-system efficiency.